Can you imagine how that would expand your perspective on your career, your relationships and your life? Now is the time to be bold!

In Bold Moves, Pippa Hallas, shares the inspiring story of her great aunt, Ella Baché, who fled war-torn Europe to start one of the world’s best loved skin care companies. Through conversations with other remarkable Australian women including Lorna Jane Clarkson, Tracy Spicer and many more, Pippa shares the moments when these women stood up, spoke out and fearlessly redefined their futures.

As women and beauty trends have evolved over the decades, Ella Baché has kept pace while holding true to the core values of the company. Pippa opens up about the journey behind the brand, the disruptions, the innovations, the mistakes, and the risks that have made it what it is today.

Featuring personal advice — as well as her own journey as CEO and as the mother of two young boys — this book will show you how to:

  • embrace your personal story
  • fortify your voice
  • design the life you want to live
  • love your own skin
  • build your personal legacy.

In a world of constant change, ground breaking technology, unprecedented transparency and unrivalled expectation, it is harder than ever to live a life of truth and passion. Bold Moves will give you everything you need to stand up and be bold in every part of your life.

Now available to purchase online, in Salons, David Jones and leading book stores.

100% of Authors proceeds go to support the Cherish Foundation.

Every year in Australia, 6,000 women will be diagnosed with gynaecological cancer. Almost one-third of these women will not do well.

Gynaecological cancers have not been researched as well as other cancers. Government funding has been drastically reduced, even though all the statistics show this cancer is increasingly prevalent. Little is known about the support women need during and after treatment. That is why the proceeds of this book will be donated to Cherish Women’s Cancer Foundation.

The primary goal of Cherish is to fund clinical research that results in kinder, gentler and more effective gynaecological cancer treatments. Cherish supports flagship Australian research projects like the feMMe Trial that aims to treat obese women with early-stage endometrial cancer less-invasively with the use of an intra-uterine device (Mirena) combined with a weight-loss program and a diabetes drug. If successful, the benefits to patients will include less hospital bed days, less radical surgery, fewer complications and lower costs to patients. Importantly, it will also allow more women to retain their fertility.